Daniel H. Kim
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
112
Citations
8,785
Est. group size
~1
Recurring co-author estimate
Active years
34
Publishing since 1993
Daniel H. Kim's research focuses on RNA biology in cancer, including how repetitive and transposable-element-derived RNAs are regulated in tumors and how these molecules might be detected in blood (liquid biopsy) for early cancer detection. Work also touches on gene regulation processes like chromatin accessibility in stem cells and signaling pathways (e.g., Notch) in cancer cell behavior. Methods draw on sequencing technologies such as nanopore long-read sequencing and single-cell RNA sequencing.
Publication output was low and irregular from 2017-2021, rose notably with a peak of 14 outputs in 2023, then declined in 2024-2025, suggesting an uneven but recently active publication pattern.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Inwardly rectifying potassium channels regulate membrane potential polarization and direction sensing during neutrophil chemotaxis
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- RNA liquid biopsy via nanopore sequencing for novel biomarker discovery and cancer early detection
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- 51977 Classification and Grading of Dermatologic Adverse Events from Anti-Cancer Therapies: A Multi-Center Study of Dermatology and Medical Oncology Physicians
Journal of the American Academy of Dermatology · 2024
- Abstract A023: Advancing RNA liquid biopsy technology via long-read sequencing
Clinical Cancer Research · 2024
- Profiling of repetitive RNA sequences in the blood plasma of patients with cancer
Nature Biomedical Engineering · 2023
- Dynamics of Chromatin Accessibility During Hematopoietic Stem Cell Differentiation Into Progressively Lineage-Committed Progeny
Stem Cells · 2023
- Transposable element RNA dysregulation in mutant KRAS(G12C) 3D lung cancer spheroids
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Abstract 6505: ColoScape test: a molecular assay to detect early-stage colorectal cancer in plasma cell-free DNA
Cancer Research · 2023
- Data from Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells
2023
- Supplemental Figures from Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells
2023
- Data from Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells
2023
- Supplemental Methods from Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells
2023
- Supplemental Figures from Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells
2023
- Supplemental Table1 from Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells
2023
- ISID1171 - Single-cell RNA sequencing confirms MMP2 as the primary matrix metalloproteinase implicated in the photoaging of keratinocytes
2023
- bioRxiv (Cold Spring Harbor Laboratory)×7
- Journal of the American Academy of Dermatology×5
- Fish & Shellfish Immunology×4
- Nano Today×1
- International Journal of Radiation Oncology*Biology*Physics×1
- Jill L. Reiter
Biochemistry, Genetics and Molecular Biology · Indiana University
- Lauren A. Woodward
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Caleb M. Embree
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Dawn S. Chandler
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Maria C. Sterrett
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile